Artelo Biosciences, Inc. (ARTL)
USD 0.97
(17.95%)
USD 0.97
(17.95%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 10.28 Million | 7.44 Million | 4.68 Million | 3.2 Million | 2.34 Million | 232.78 Thousand |
| Selling, General and Administrative Expenses | 5.96 Million | 4.6 Million | 2.76 Million | 2.11 Million | 1.09 Million | 232.78 Thousand |
| Research and Development Expenses | 4.32 Million | 2.83 Million | 1.91 Million | 1.09 Million | 1.24 Million | - |
| Other Expenses | - | - | 1412.00 | 31.25 Thousand | 290.00 | 3332.00 |
| Cost and Expenses | 10.28 Million | 7.44 Million | 4.68 Million | 3.2 Million | 2.34 Million | 232.78 Thousand |
| Operating Income | -10.28 Million | -7.44 Million | -4.68 Million | -3.2 Million | -2.34 Million | -232.78 Thousand |
| Interest Expense | 5000.00 | - | - | - | - | 2100.00 |
| Income Tax Expense | -209 Thousand | -4000.00 | -60.41 Thousand | -2.04 Million | 8.00 | - |
| Earnings before Tax | -10.08 Million | -7.43 Million | -4.65 Million | -2.17 Million | -2.34 Million | -234.88 Thousand |
| Net Income | -9.87 Million | -7.43 Million | -4.65 Million | -2.17 Million | -2.34 Million | -234.88 Thousand |
| Earnings Per Share Basic | -3.49 | -5.97 | -18.83 | -15.00 | -27.52 | -3.23 |
| Earnings Per Share Diluted | -3.49 | -5.97 | -18.83 | -15.00 | -27.52 | -3.23 |
| Weighted Average Shares Outstanding | 2.83 Million | 1.24 Million | 247 Thousand | 144 Thousand | 84 Thousand | 72 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 2.83 Million | 1.24 Million | 247.17 Thousand | 144.83 Thousand | 85.16 Thousand | 72.77 Thousand |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -10.28 Million | -7.44 Million | -4.71 Million | -4.21 Million | -2.34 Million | -232.78 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 2.44 Million | 1.78 Million | 2.29 Million | 10.28 Million | 3.47 Million | 2.39 Million |
| Selling, General and Administrative Expenses | 1.02 Million | 1.03 Million | 1.05 Million | - | 1.75 Million | 1.31 Million |
| Research and Development Expenses | 1.58 Million | 752 Thousand | 1.23 Million | - | 1.72 Million | 1.07 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 2.44 Million | 1.78 Million | 2.29 Million | 10.28 Million | 3.47 Million | 2.39 Million |
| Operating Income | -2.61 Million | -1.78 Million | -2.29 Million | -10.28 Million | -3.47 Million | -2.39 Million |
| Interest Expense | - | - | -124 Thousand | 5000.00 | -140 Thousand | 5000.00 |
| Income Tax Expense | 165 Thousand | - | -124 Thousand | -209 Thousand | -140 Thousand | -69 Thousand |
| Earnings before Tax | -2.44 Million | -1.59 Million | -2.16 Million | -10.08 Million | -3.33 Million | -2.33 Million |
| Net Income | -2.44 Million | -1.59 Million | -2.04 Million | -9.87 Million | -3.19 Million | -2.26 Million |
| Earnings Per Share Basic | -0.83 | -0.56 | -0.72 | - | -1.13 | -0.79 |
| Earnings Per Share Diluted | -0.83 | -0.56 | -0.72 | - | -1.13 | -0.79 |
| Weighted Average Shares Outstanding | 2.94 Million | 2.85 Million | 2.85 Million | 2.83 Million | 2.82 Million | 2.84 Million |
| Weighted Average Shares Outstanding (Diluted) | 2.94 Million | 2.85 Million | 2.85 Million | 2.83 Million | 2.83 Million | 2.84 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | 165 Thousand | -1.96 Million | -2.41 Million | - | -3.47 Million | -2.39 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
STGN
SLBEN
FGFL
IDDWF
461030
COP